Literature DB >> 15459948

Development of an in vitro model for premature neonatal skin: biophysical characterization using transepidermal water loss.

N Sekkat1, Y N Kalia, R H Guy.   

Abstract

The objective was to develop an in vitro model for the developing skin of the premature neonate. Barriers of different levels of efficiency were produced by differentially tape-stripping the stratum corneum (SC) from the skin of excised porcine ears, and were characterized by measurements of transepidermal water loss (TEWL). In this way, it was possible to express the recorded TEWL as a function of percentage SC thickness (F) generating the following relationship: TEWL = 2.7 + 41.exp [- 0.028.F]. These data were then compared to previously published in vivo measurements of TEWL obtained from a population of premature neonates at various post-conceptional ages (PCA). The latter conformed to a remarkably parallel relationship to that found in vitro with the porcine skin model, namely TEWL = 3.3 + 41.exp [-0.026.(PCA-160)]. It can be suggested, therefore, that the empirically adjusted PCA (i.e., PCA-160) correlates closely with the developing thickness of the neonate's SC. The corollary is that porcine skin, in vitro, tape-stripped to a particular level, can provide a barrier corresponding to a specific degree of neonate maturation and can serve, hence, as a useful tool with which to explore whether transdermal drug delivery in this unique patient population may be beneficial. (c) 2004 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Year:  2004        PMID: 15459948     DOI: 10.1002/jps.20195

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  Porcine ear skin as a model for the assessment of transdermal drug delivery to premature neonates.

Authors:  Nabila Sekkat; Yogeshvar N Kalia; Richard H Guy
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  The local vasoconstriction of infant's skin following instillation of mydriatic eye drops.

Authors:  Atilla Alpay; Bahri Ermis; Silay C Ugurbas; Fatih Battal; Haci Murat Sagdik
Journal:  Eur J Clin Pharmacol       Date:  2010-09-11       Impact factor: 2.953

3.  A novel approach toward noninvasive monitoring of transcutaneous CO(2).

Authors:  Madhubanti Chatterjee; Xudong Ge; Yordan Kostov; Leah Tolosa; Govind Rao
Journal:  Med Eng Phys       Date:  2013-08-06       Impact factor: 2.242

4.  The Influence of Formulation and Excipients on Propranolol Skin Permeation and Retention.

Authors:  Cristina Padula; Sara Nicoli; Silvia Pescina; Patrizia Santi
Journal:  Biomed Res Int       Date:  2018-08-02       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.